“I buy on the assumption that they could close the market the next day and not reopen it for five years.”
— Warren Buffett
The Warren Buffett investment philosophy calls for a long-term investment horizon, where a five year holding period, or even longer, would fit right into the strategy. How would such a strategy have worked out for an investment into Biogen Inc (NASD: BIIB)? Today, we examine the outcome of a five year investment into the stock back in 2017.
| Start date: | 03/02/2017 |
|
|||
| End date: | 03/01/2022 | ||||
| Start price/share: | $293.59 | ||||
| End price/share: | $210.34 | ||||
| Starting shares: | 34.06 | ||||
| Ending shares: | 34.06 | ||||
| Dividends reinvested/share: | $0.00 | ||||
| Total return: | -28.36% | ||||
| Average annual return: | -6.45% | ||||
| Starting investment: | $10,000.00 | ||||
| Ending investment: | $7,165.05 | ||||
As we can see, the five year investment result worked out poorly, with an annualized rate of return of -6.45%. This would have turned a $10K investment made 5 years ago into $7,165.05 today (as of 03/01/2022). On a total return basis, that’s a result of -28.36% (something to think about: how might BIIB shares perform over the next 5 years?). [These numbers were computed with the Dividend Channel DRIP Returns Calculator.]
One more piece of investment wisdom to leave you with:
“Investing is the intersection of economics and psychology.” — Seth Klarman
